Latest Articles and Analysis

Antibiotic-resistant bacteria threaten basic medical procedures while drug development incentives prove inadequate for innovation.

Pharmacy benefit managers extract billions while adding no value, increasing costs without improving patient access or health outcomes.

Elimination of HIV data protections and surveillance capacity undermines disease tracking and outbreak response capability.

Trump administration's contradictory drug pricing policies undermine goals of affordability and innovation incentives.

State Prescription Drug Affordability Boards limit public input while basing pricing decisions on flawed methodologies.

Deteriorating public health surveillance capacity creates blind spots for emerging disease threats and health disparities.

Copay accumulator programs exclude patient assistance from deductibles, creating barriers to medication adherence and treatment.

Declining vaccination rates and policy challenges create vulnerability to vaccine-preventable diseases and epidemic risk.

Convergence of influenza, avian flu, and tuberculosis threats reveals inadequate pandemic preparedness and disease response capacity.

Elimination of health equity research funding undermines evidence base for addressing healthcare disparities and structural inequalities.

Elimination of surveillance funding creates blind spots in disease tracking and health equity measurement.

Proposed Medicaid cuts and work requirements threaten coverage for millions including people living with HIV.

FTC investigation confirms pharmacy benefit managers extracted billions in excess revenue through specialty drug markup schemes.

Insurance companies deploy AI algorithms for automated prior authorization denials, restricting patient access to prescribed treatments.

Reflection on advocacy values and health equity commitment during political transitions.

Healthcare policy opportunities and threats during lame duck congressional session.

CDC progress data on STI and overdose prevention initiatives shows mixed results.

World AIDS Day reflection on ending the HIV epidemic: challenges and opportunities.

Bipartisan HCV elimination legislation analysis and critical legislative window.

Partisan political battles threaten essential public health programs and HIV funding.